Position in OCGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$30,770
+$5,120 QoQ
Shares Held
17,000
-10.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $8,781,235 across 9 Biotechnology names. OCGN ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,524 | $4,252,846 | |
| 2 | GMAB |
Genmab A/S
|
57,023 | $1,529,927 | |
| 3 | ARGX |
Argenx SE
|
1,131 | $825,912 | |
| 4 | CELC |
Celcuity Inc.
|
6,417 | $732,436 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
895 | $691,512 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,471 | $656,192 | |
| 7 | MNKD |
Mannkind Corp
|
21,098 | $51,690 | |
| 8 | OCGN |
Ocugen, Inc.
This page
|
17,000 | $30,770 |
All Filings in OCGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,770 | 17,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $25,650 | 19,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,970 | 19,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $18,430 | 19,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $13,767 | 19,500 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||